Mechanisms of cytokine synergy essential for vaccine protection against viral challenge

International Immunology

Volumn 13, Issue 7, 2001, Pages 897-908

  Ahlers, J D ^a   Belyakov, I M ^a   Matsui, S ^a   Berzofsky, J A ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Cytokines; Cytotoxic T lymphocyte; Th1 cells; Viral immunity

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; CYTOKINE; GAMMA INTERFERON; GLYCOPROTEIN GP 160; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 12; PEPTIDE; TUMOR NECROSIS FACTOR ALPHA; VACCINE;

ADOPTIVE TRANSFER; ANIMAL CELL; ANTIBODY RESPONSE; ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; ARTICLE; CELL ACTIVITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; DRUG POTENTIATION; FEMALE; HELPER CELL; IMMUNE RESPONSE; IMMUNIZATION; IN VIVO STUDY; LABORATORY; LYMPH NODE; MOUSE; MOUSE STRAIN; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTECTION; PROTEIN EXPRESSION; TH1 CELL; TH2 CELL; VACCINATION; VACCINIA; VIRUS RECOMBINANT;

EID: 0034922197     PISSN: 09538178     EISSN: None     Source Type: Journal    
DOI: 10.1093/intimm/13.7.897     Document Type: Article

References (88)

1. Cytokine-in-adjuvant steering of the immune response phenotype to HIV-1 vaccine constructs: GM-CSF and TNF-α synergize with IL-12 to enhance induction of CTL
2. Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity
3. Antitumor and antimetastatic activity of interleukin 12 against murine tumors
4. Manipulation of the immune response to a plasmid-encoded viral antigen by coinoculation with plasmids expressing cytokines
5. Cytokine enhancement of DNA immunization leads to effective treatment of established pulmonary metastases
6. Granulocyte-macrophage colony-stimulating factor: An effective adjuvant for protein and peptide-based vaccines
7. In vivo engineering of a cellular immune response by coadministration of IL-12 expression vector with a DNA immunogen
8. Enhanced CTL responses mediated by plasmid DNA immunogens encoding costimulatory molecules and cytokines
9. Adsorption to aluminum hydroxide promotes the activity of IL-12 as an adjuvant for antibody as well as type 1 cytokine responses to HIV-1 gp120
10. A plasmid encoding murine granulocyte-macrophage colony-stimulating factor increases protection conferred by a malaria DNA vaccine
11. + cytotoxic T lymphocytes in the absence of exogenous help
12. IL-12 is an effective adjuvant to recombinant vaccinia virus-based tumor vaccines: Enhancement by simultaneous B7-1 expression
13. Dendritic cells infiltrating tumors cotransduced with granulocyte/macrophage colony-stimulating factor (GM-CSF) and CD40 ligand genes take up and present endogenous tumor-associated antigens, and prime lymphocyte response
14. CTLA-4 blockade synergizes with tumor-derived granulocyte-macrophage colony-stimulating factor for treatment of an experimental mammary carcinoma
15. Construction of an HIV-1 peptide vaccine containing a multideterminant helper peptide linked to a V3 loop peptide 18 inducing strong neutralizing antibody responses in mice of multiple MHC haplotypes after two immunizations
16. + CTL in vivo with peptide vaccine constructs
17. Candidate HIV type1 multideterminant cluster peptide-P18MN vaccine constructs elicit type1 helper T cells, cytotoxic T cells, and neutralizing antibody, all using the same adjuvant immunization
18. Reciprocal control of T helper cell and dendritic cell differentiation
19. + T cell help
20. T cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions
21. Help for cytotoxic-T cell responses is mediated by CD40 signalling
22. + T-helper and a T-killer cell
23. CD40-CD40 ligand costimulation is required for generating antiviral CD4 T cell responses but is dispensable for CD8 T cell responses
24. Dendritic cells and the control of immunity
25. Generation of tumor immunity by bone marrow-derived dendritic cells correlates with dendritic cell maturation stage
26. Dendritic cells require maturation via CD40 to generate protective antitumor immunity
27. Blocking the CD40L-CD40 interaction in vivo specifically prevents the priming of T helper 1 cells through the inhibition of interleukin 12 secretion
28. + T cells
29. Interleukin-12: A cytokine at the interface of inflammation and immunity
30. Dendritic cell secretion of IL-15 is induced by recombinant huCD40LT and augments the stimulation of antigen-specific cytolytic T cells
31. Viral induction of co-stimulatory activity on antigen-presenting cells bypasses the need for CD4 T cell help in CD8 T cell responses
32. + helper cell requirement in cytotoxic T lymphocyte responses
33. + CTL by immunization with syngeneic irradiated HIV-1 envelope derived peptide-pulsed dendritic cells
34. Protective antiviral cytotoxic T cell memory is most efficiently maintained by restimulation via dendritic cells
35. + T cells correlating with cytotoxic activity in vitro are more efficient in antivaccinia virus protection than CD4-dependent IL
36. + T lymphocytes and macrophage subsets in the control of a generalized virus infection
37. + T cell responses associated with control of viremia
38. + T cells against influenza virus induced by vaccination with nucleoprotein DNA
39. Viral immune evasion due to persistence of activated T cells without effector function
40. Impaired generation of anti-viral cytotoxicity against lymphocytic choriomeningitis and vaccinia virus in mice treated with CD4-specific monoclonal antibody
41. + cells after a transient response to antigen
42. + T cells
43. + T cell-mediated antiviral protection
44. Antiviral defense in mice lacking both alpha/beta and gamma interferon receptors
45. A critical role for neutralizing-antibody-producing B cells, CD4(+) T cells, and interferons in persistent and acute infections of mice with lymphocytic choriomeningitis virus: Implications for adoptive immunotherapy of virus carriers
46. Low-affinity cytotoxic T-lymphocytes require IFN-γ to clean an acute viral infection
47. Protective role of gamma interferon during the recall response to influenza virus
48. + T cell-deficient mice
49. The critical need for CD4 help in maintaining effective cytotoxic T lymphocyte responses
50. CD4-deficient mice have reduced levels of memory cytotoxic T lymphocytes after immunization and show diminished resistance to subsequent virus challenge
51. + CTL response
52. h1 cytokine responses as well as delayed virus clearance
53. + T helper type 2 T lymphocytes do not promote recovery from experimental virus infection
54. h2 responses
55. IL-10 inhibits cytokine production by activated macrophages
56. Cytokines induce the development of functionally heterogeneous T helper cell subsets
57. + T cells through IL-12 produced by Listeria-induced macrophages
58. + T cells to enhance priming for IFNγ production and diminishes IL-4 inhibition of such priming
59. + T cells requires the coordinate action of interleukin-12 and interferon-γ and is inhibited by transforming growth factor-β
60. Roles of IFN-γ in IL-12-induced T helper cell-1 development
61. + T cells
62. Differential regulation of T helper phenotype development by interleukins 4 and 10 in an αβ T cell-receptor transgenic system
63. h2 lineage by extinction of IL-12 signaling
64. IL-4 inhibits the production of TNF-α and IL-12 by STAT6-dependent and - Independent mechanisms
65. Selective expansion of high or low avidity cytotoxic T lymphocytes and efficacy for adoptive immunotherapy
66. Mucosal immunization with HIV-1 peptide vaccine induces mucosal and systemic cytotoxic T lymphocytes and protective immunity in mice against intrarectal recombinant HIV-vaccinia challenge
67. + cytotoxic T lymphocytes for resistance to mucosal-viral transmission in mice and enhancement of resistance by local administration of IL-12
68. Administration of recombinant IL-12 to normal mice enhances cytolytic lymphocyte activity and induces production of IFN-γ in vivo
69. Modulation of amplitude and direction of in vivo immune responses by co-administration of cytokine gene expression cassettes with DNA immunogens
70. + T cells during the primary immune response to Epstein-Barr virus in vivo
71. Counting antigen-specific CD8 T cells: A reevaluation of bystander activation during viral infection
72. β usage during the primary immune response to HIV
73. Temporal association of cellular immune responses with the initial control of viremia in primary human imunodeficiency virus type 1 syndrome
74. Viral escape by selection of cytotoxic T cell-resistant virus variants in vivo
75. Antiviral protection by virus-immune cytotoxic T cells: Infected target cells are lysed before infectious virus progeny is assembled
76. Antiviral pressure exerted by HIV-1-specific cytotoxic T lymphocytes (CTLs) during primary infection demonstrated by rapid selection of CTL escape virus
77. + T cells upon acute versus persistent viral infection
78. Protection against immunopathological consequences of a viral infection by activated but not resting cytotoxic T cells: T cell memory without 'memory T cells'?
79. Gamma interferon-induced, nitric oxide-mediated inhibition of vaccinia virus replication
80. Inflammatory stimuli induce accumulation of MHC class II complexes on dendritic cells
81. Activated T cells induced inteleukin-12 production by monocytes via CD40-CD40 ligand interaction
82. Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activation
83. h1 cells producing high levels of IFN-γ in BALB/c but not C57BL/6 mice
84. Supra-optimal peptide/MHC causes a decrease in Bcl-2 and allows TNF-α receptor II-mediated apoptosis of CTL
85. Differential roles of IL-1 and TNF-α on graft-versus-host disease and graft versus leukemia
86. T cell genetic background determines default T helper phenotype development in vitro
87. Adjuvant-guided type-1 and type-2 immunity: Infectious/noninfectious dichotomy defines the class of response
88. Interplay of cytokines and adjuvants in the regulation of mucosal and systemic HIV-specific cytotoxic T lymphocytes